Global Neuromodulation Devices Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Oct 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Neuromodulation Devices Market By Product Type (Internal Neuromodulation, External Neuromodulation), End- User (Hospitals, Clinics, Home Healthcare, Others), Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Neuromodulation Devices Market

Global neuromodulation devices market is set witness a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Rising cases of neurological disorders and miniaturization of devices are the factor for the market growth.

Market Definition: Global Neuromodulation Devices Market

Neuromodulation is a prolific technology that uses electricity or chemical agents in the body to stimulate specific neurological sites or alter nerve activity. They are widely used for the treatment of condition such as epilepsy, Parkinson disease, dystonia and other. Mostly neuromodulation devices use electrical stimulation. These devices are widely used in application such as spinal cord stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electric nerve stimulation among others.

Market Drivers

  • Technological advancement in neuromodulation devices will drive the market growth
  • Increasing number of clinical trial worldwide also acts as a market driver
  • Rising aging population is another factor boosting the market growth
  • Increasing approval rate of neurostimulators will also contribute as a factor for this market growth

Market Restraints

  • Lack of skilled and trained professional will restrict the growth of this market in the forecast period
  • High investment cost will also hamper the market growth
  • Unfavorable repayment policies will also impede the growth of this market

Segmentation: Global Neuromodulation Devices Market

By Product Type

  • Internal Neuromodulation
  • External Neuromodulation

By End- User

  • Hospitals
  • Clinics
  • Home Healthcare
  • Others

By Application

  • Spinal Cord Stimulation

    • Chronic Pain Management
    • Failed Back Syndrome (FBSS)
    • Ischemia

  • Deep Brain Stimulation

    • Parkinson’s Disease
    • Tremor
    • Depression
    • Others

  • Sacral Nerve Stimulation

    • Urine Incontinence
    • Fecal Incontinence

  • Vagus Nerve Stimulation

    • Epilepsy
    • Others

  • Gastric Electrical Stimulation

    • Gastroparesis
    • Obesity

  • Transcutaneous Electrical Nerve Stimulation

    • Treatment-Resistant Depression
    • Other

  • Repetitive Transcranial Magnetic Stimulation

    • Depression
    • Migraine Headache

  • Respiratory Electrical Stimulation

    • Spinal Cord Injury
    • Other

By Biomaterial

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In October 2018, Heraeus Medical Components announced the acquisition of Evergreen Medical Technologies. This acquisition will help the company so they can provide different neuromodulation solutions to its medical device customers. With this acquisition, they can enhance their supply chain and provide cost effective solution to market
  • In July 2016, Boston Scientific announced the acquisition Cosman Medical so they can enhance their neuromodulation portfolio. This will help the company to provide better treatment for the chronic diseases and also provide access to the Cosman’s radiofrequency ablation systems which is specially designed for neurosurgery and pain management. This will expand the Boston portfolio and will strengthen their market position

Competitive Analysis:

Global neuromodulation devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of neuromodulation devices market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global neuromodulation devices market are Medtronic; Boston Scientific Corporation; Nevro Corp.; NeuroSigma, Inc; NeuroPace, Inc.; Abbott.; Soterix Medical Inc; Synapse Biomedical Inc.; ReShape Lifesciences, Inc.; Bioness Inc.; Aleva Neurotherapeutics SA; LivaNova PLC; Neuronetics; Cyberonics, Inc; Neuromod; Axonics Modulation Tech; The Magstim Company Limited; Sooma Oy; CVRx; Helius Medical Technologies; WISE Srl; among others.

Research Methodology: Global Neuromodulation Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global neuromodulation devices market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us